Literature DB >> 4060378

[Testicular and epididymal metastasis of prostate cancer].

W Thon, W Mohr, J E Altwein.   

Abstract

Metastatic testicular carcinoma is unusual. A case of carcinoma of the prostate with metastases to the testis and epididymis is reported. Routes of metastatic spread of neoplasm to the testis are discussed. Easily removable cancer may remain in the scrotum when using the socalled subcapsular orchiectomy without complete removal of the scrotal contents.

Entities:  

Mesh:

Year:  1985        PMID: 4060378

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  5 in total

Review 1.  [Testicular metastasis of a metachronous small cell neuroendocrinic prostate cancer after anti-hormonal therapy of a prostatic adenocarcinoma. Case report and literature review].

Authors:  A Schneider; A Kollias; J Woziwodzki; G Stauch
Journal:  Urologe A       Date:  2006-01       Impact factor: 0.639

2.  Prostatic adenocarcinoma presenting with metastases to the testis and epididymis: A case report.

Authors:  Jin Zhang; Mei Dong; Xiaolei Hu; Lin Liu; Shen Li; Chao Li; Lijun Yang; Yongqiang Xiao; Shujian Pang; Chuan Wang
Journal:  Oncol Lett       Date:  2015-11-16       Impact factor: 2.967

3.  Prostate cancer metastatic to bilateral testicles: case report and literature review.

Authors:  Zachary M Connelly; Ahmad Azzawe; Ashley Flowers; Adnan Fazili; Cole Craighead; Nazih Khater
Journal:  Am J Clin Exp Urol       Date:  2021-04-15

4.  Isolated Testicular Metastasis from Prostate Cancer.

Authors:  Alberto Bonetta; Daniele Generali; Silvia Paola Corona; Gianni Cancarini; Sarah Grazia Brenna; Chiara Pacifico; Giandomenico Roviello
Journal:  Am J Case Rep       Date:  2017-08-14

5.  [Symptomatic testicular metastasis of acinar adenocarcinoma of the prostate].

Authors:  L Kollitsch; C Hamann; S Knüpfer; D Meyer; P Kneissl; E Jüttner; D Osmonov
Journal:  Urologe A       Date:  2020-09       Impact factor: 0.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.